- Home
- ANEB vs TIMB Comparison
ANEB vs TIMB Comparison
Compare ANEB & TIMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- TIMB
- Stock Information
- Founded
- ANEB 2020
- TIMB 1998
- Country
- ANEB United States
- TIMB Brazil
- Employees
- ANEB N/A
- TIMB N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- TIMB Telecommunications Equipment
- Sector
- ANEB Health Care
- TIMB Telecommunications
- Exchange
- ANEB Nasdaq
- TIMB Nasdaq
- Market Cap
- ANEB 111.8M
- TIMB 94.1M
- IPO Year
- ANEB 2021
- TIMB 1998
- Fundamental
- Price
- ANEB $2.76
- TIMB $23.07
- Analyst Decision
- ANEB Buy
- TIMB Hold
- Analyst Count
- ANEB 2
- TIMB 4
- Target Price
- ANEB $8.00
- TIMB $20.50
- AVG Volume (30 Days)
- ANEB 25.7K
- TIMB 318.3K
- Earning Date
- ANEB 11-12-2025
- TIMB 11-03-2025
- Dividend Yield
- ANEB N/A
- TIMB 6.25%
- EPS Growth
- ANEB N/A
- TIMB 16.41
- EPS
- ANEB N/A
- TIMB 0.27
- Revenue
- ANEB N/A
- TIMB $4,779,664,328.00
- Revenue This Year
- ANEB N/A
- TIMB $8.08
- Revenue Next Year
- ANEB N/A
- TIMB $5.29
- P/E Ratio
- ANEB N/A
- TIMB $16.56
- Revenue Growth
- ANEB N/A
- TIMB 5.32
- 52 Week Low
- ANEB $0.80
- TIMB $11.32
- 52 Week High
- ANEB $3.42
- TIMB $22.90
- Technical
- Relative Strength Index (RSI)
- ANEB 64.17
- TIMB 68.84
- Support Level
- ANEB $2.50
- TIMB $21.74
- Resistance Level
- ANEB $2.76
- TIMB $22.20
- Average True Range (ATR)
- ANEB 0.12
- TIMB 0.37
- MACD
- ANEB 0.03
- TIMB 0.15
- Stochastic Oscillator
- ANEB 85.00
- TIMB 94.50
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About TIMB TIM S.A. (Each representing 5)
TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.